Category: General Surgery

Single-port robotic surgery shows promise for rectal cancer

An international registry of 104 rectal cancer surgeries using single port robotic technology reported successful outcomes. The procedure demonstrated a 97.1% completeness in total mesorectal excision specimens and a low R1 margin rate of 3.8%. Operating time averaged 168 minutes with no intraoperative complications and a conversion rate of just 1.9%. With a total of […]

Proficiency in robot-assisted esophagectomy improves after 27 cases

A study on robot-assisted minimally invasive McKeown esophagectomy revealed a significant reduction in operation time associated with increased surgical proficiency. Analyzing 83 cases, researchers found that transitioning from the initial learning phase (cases 1-27) to the proficiency phase (cases 28-83) resulted in a drop in mean operation time from 329.6 minutes to 221.3 minutes (p

Triplet induction chemotherapy shows high response in rectal cancer

The study demonstrated that triplet induction chemotherapy with folfirinox results in an objective response rate of 80% and a disease control rate of 92% in patients with synchronous metastatic rectal cancer (smrc). Analysis of 146 patients revealed that 69% of those with resectable metastases underwent rectal surgery after treatment. Moreover, survival outcomes were notable, with […]

Liver venous deprivation is safe and promotes liver growth.

A multicentric study demonstrated the safety and efficacy of liver venous deprivation (LVD) in enhancing future liver remnant (FLR) volume prior to major hepatectomy. Out of 192 patients, LVD achieved a 100% technical success rate, with only a 2.6% rate of severe complications. FLR volume increased by an average of 61.7% within 27 days. Although […]

New colorectal anastomotic devices show lower leak rates

A recent systematic review and meta-analysis examined alternative colorectal anastomotic devices, finding a pooled complication rate of 9.7% in human studies. Notably, the leak rate for compression anastomoses was only 3.3%, demonstrating no variation among studies. This review included 18 studies with a total of 955 anastomoses and highlighted significant advancements in new technologies, particularly […]

Mesh Bridging Improves Outcomes in Burst Abdomen Repairs

Findings indicate that using mesh bridging for temporary closure of burst abdomen significantly reduces hospital stays and severe complications compared to negative pressure wound therapy (NPWT). Among 119 patients studied, those receiving mesh bridging had a remarkable average stay of 29 days, opposed to 93 days with NPWT. Furthermore, mesh bridging led to fewer severe […]

Evidence-based perioperative safety recommendations are inconsistent.

A systematic review of 267 clinical practice guidelines revealed significant variability in perioperative patient safety recommendations. Among 4,666 recommendations identified, 44.9% were strongly endorsed; however, only 18 guidelines excelled in methodological quality. A notable gap was found in recommendations related to pre-admission and post-discharge care. These findings underscore the inconsistency between the strength of recommendations […]

Surgical resection improves survival for gastric cancer liver metastases

A population-based analysis of 3,694 gastric cancer patients with liver metastases revealed that those undergoing cancer-directed surgery experienced significantly longer median overall survival, 12 months versus 6 months for non-resection patients. After adjusting for selection bias, Cox regression indicated a substantial survival benefit, with a hazard ratio of 0.562. These findings highlight the importance of […]

Early recurrence in IPMN-derived pancreatic cancer is predictable.

In an international multicenter study, early recurrence in resected intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic cancer was identified at 10.5 months. Among 381 patients, 42% experienced recurrence, with 38% classified as early recurrences. Key predictors included CA19-9 levels and N2 disease staging. The study stratified patients into low, intermediate, and high-risk groups, revealing that adjuvant […]

Preoperative TACE enhances survival in intermediate-stage liver cancer

In patients with intermediate-stage hepatocellular carcinoma (HKLC stage IIB), preoperative transarterial chemoembolization (TACE) significantly improves survival outcomes compared to upfront surgery alone. A study involving 154 matched patients found that the median overall survival for the TACE group undergoing surgical resection was 90.97 months, versus 30.68 months for the surgery-only group. Additionally, disease-free survival was […]